Huai Qi Huang-induced Apoptosis via Down-regulating PRKCH and Inhibiting RAF/MEK/ERK Pathway in Ph+ Leukemia Cells
Huai Qi Huang-induced Apoptosis via Down-regulating PRKCH and Inhibiting RAF/MEK/ERK Pathway in Ph+ Leukemia Cells
复制标题
槐杞黄通过下调PRKCH并抑制RAF/MEK/ERK通路诱导Ph白血病细胞凋亡
DOI:
10.1007/s11596-020-2181-5
复制
发表时间:
2020-04
影响因子:
2.4
通讯作者:
Jin Run-ming
中科院分区:
文献类型:
--
作者:
Xu Wen-fu;Wang Zhu-jun;Li Kun;Shen Ya-qing;Lu Ke;Lv Xue-yan;Wen Yu-xi;Jin Run-ming
Imatinib mesylate (IM) is the first-line treatment for Philadelphia (Ph) chromosomal positive leukemia by inhibiting phosphorylation of substrates via binding to the ABL kinase domain. Because of the drug resistance, side effects and the high cost of IM,
登录
查看更多内容
影响因子:
7.3
作者:
Colicelli J
通讯作者:
Colicelli J
影响因子:
11.2
作者:
Cunningham, Steven C.;Gallmeier, Eike;Kern, Scott E.
通讯作者:
Kern, Scott E.
影响因子:
82.9
作者:
T. Vilimas;J. Mascarenhas;Teresa Palomero;M. Mandal;S. Buonamici;Fanyong Meng;B. Thompson;Christina Sp
通讯作者:
T. Vilimas;J. Mascarenhas;Teresa Palomero;M. Mandal;S. Buonamici;Fanyong Meng;B. Thompson;Christina Sp
影响因子:
20.3
作者:
Jones, Courtney L.;Gearheart, Christy M.;Carroll, William L.
通讯作者:
Carroll, William L.
DOI:
10.1016/j.yonc.2012.07.028
发表时间:
2012
期刊:
Yearbook of Oncology
影响因子:
--
作者:
A. Hamilton;G. Helgason;M. Schemionek;Bin Zhang;S. Myssina;E. Allan;F. Nicolini;C. Müller-Tidow;R. Bhatia;V. Brunton;S. Koschmieder;T. Holyoake
通讯作者:
A. Hamilton;G. Helgason;M. Schemionek;Bin Zhang;S. Myssina;E. Allan;F. Nicolini;C. Müller-Tidow;R. Bhatia;V. Brunton;S. Koschmieder;T. Holyoake